Millis D L, Wilkens B E, Daniel G B, Hubner K, Mathews A, Buonomo F C, Patell K R, Weigel J P
Department of Small Animal Clinical Sciences, University of Tennessee, USA.
Vet Surg. 1998 Mar-Apr;27(2):85-93. doi: 10.1111/j.1532-950x.1998.tb00103.x.
To determine the effect of recombinant canine somatotropin (STH) on radiographic, densitometric, and biomechanical aspects of bone healing using an unstable ostectomy gap model.
After an ostectomy of the midshaft radius, bone healing was evaluated over an 8-week period in control dogs (n = 4) and dogs receiving recombinant canine STH (n = 4).
Eight sexually intact female Beagle dogs, 4 to 5 years old.
Bone healing was evaluated by qualitative and quantitative evaluation of serial radiographs every 2 weeks. Terminal dual-energy x-ray absorptiometry and three-point bending biomechanical testing were also performed.
Dogs receiving STH had more advanced radiographic healing of ostectomy sites. Bone area, bone mineral content, and bone density were two to five times greater at the ostectomy sites of treated dogs. Ultimate load at failure and stiffness were three and five times greater in dogs receiving STH.
Using the ostectomy gap model, recombinant canine STH enhanced the radiographic, densitometric, and biomechanical aspects of bone healing in dogs.
Dogs at risk for delayed healing of fractures may benefit from treatment with recombinant canine STH.
使用不稳定骨切除术间隙模型,确定重组犬生长激素(STH)对骨愈合的影像学、骨密度测定及生物力学方面的影响。
在对桡骨中段进行骨切除术后,对对照犬(n = 4)和接受重组犬STH的犬(n = 4)在8周时间内评估骨愈合情况。
8只4至5岁、性成熟的雌性比格犬。
每2周通过对系列X光片进行定性和定量评估来评估骨愈合情况。还进行了终末期双能X线吸收法和三点弯曲生物力学测试。
接受STH的犬骨切除部位的影像学愈合更先进。治疗犬的骨切除部位的骨面积、骨矿物质含量和骨密度比对照犬大两到五倍。接受STH的犬在失效时的极限负荷和刚度分别是对照犬的三倍和五倍。
使用骨切除术间隙模型,重组犬STH增强了犬骨愈合的影像学、骨密度测定及生物力学方面。
有骨折延迟愈合风险的犬可能受益于重组犬STH治疗。